Interestingly, the modulation of Hif-1α expression can affect the sensitivity to radiotherapy in thyroid neoplasia and to chemotherapy in multiple tumours [77], making it a promising therapeutic target for many cancer types, including thyroid carcinomas [78]. Here, HIF1A is linked to neoplasm.